Advertisement

Annals of Surgical Oncology

, Volume 22, Issue 9, pp 2902–2911 | Cite as

Disparities in Breast Cancer Surgery Delay: The Lingering Effect of Race

  • Vanessa B. Sheppard
  • Bridget A. Oppong
  • Regina Hampton
  • Felicia Snead
  • Sara Horton
  • Fikru Hirpa
  • Echo J. Brathwaite
  • Kepher Makambi
  • S. Onyewu
  • Marc Boisvert
  • Shawna Willey
Breast Oncology

Abstract

Background

Delays to surgical breast cancer treatment of 90 days or more may be associated with greater stage migration. We investigated racial disparities in time to receiving first surgical treatment in breast cancer patients.

Methods

Insured black (56 %) and white (44 %) women with primary breast cancer completed telephone interviews regarding psychosocial (e.g., self-efficacy) and health care factors (e.g., communication). Clinical data were extracted from medical charts. Time to surgery was measured as the days between diagnosis and definitive surgical treatment. We also examined delays of more than 90 days. Unadjusted hazard ratios (HRs) examined univariate relationships between delay outcomes and covariates. Cox proportional hazard models were used for multivariate analyses.

Results

Mean time to surgery was higher in blacks (mean 47 days) than whites (mean 33 days; p = .001). Black women were less likely to receive therapy before 90 days compared to white women after adjustment for covariates (HR .58; 95 % confidence interval .44, .78). Health care process factors were nonsignificant in multivariate models. Women with shorter delay reported Internet use (vs. not) and underwent breast-conserving surgery (vs. mastectomy) (p < .01).

Conclusions

Prolonged delays to definitive breast cancer surgery persist among black women. Because the 90-day interval has been associated with poorer outcomes, interventions to address delay are needed.

Keywords

Breast Cancer Human Epidermal Growth Factor Receptor Black Woman Patient Navigation Breast Cancer Outcome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

Supported in part by grants from the American Cancer Society (Sheppard: PI MRSGT-06-132 CPPB), Komen for the Cure Inc. (PI: Sheppard POP0503398), and the National Cancer Institute (Mandelblatt: RO1 CA124924, RO1 CA 127617, and KO5 CA96940). We thank all the research, support, and clinical staff members who helped recruit women. We also acknowledge the support of Becky Montalvo and the Love/Avon Army of Women, including Dr. Susan Love and Leah Wilcox.

Disclosure

The authors declare no conflict of interest.

References

  1. 1.
    American Cancer Society. Breast cancer: facts and figures, 2013–2014. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. Accessed Jan 2015.
  2. 2.
    Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94:666–8.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Komenaka IK, Martinez ME, Pennington RE Jr, et al. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst. 2010;102:1178–87.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferdaus R, Kim MS, Larson JS. Health disparity: time delay in the treatment of breast cancer in Louisiana. J Health Hum Serv Adm. 2011;34:302–24.PubMedGoogle Scholar
  5. 5.
    Dehal A, Abbas A, Johna S. Racial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample database. Breast Cancer Res Treat. 2013;139:561–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Ryerson AB, Benard VB, Major AC. National breast and cervical cancer early detection program: 1991–2002 national report. http://www.cdc.gov/cancer/nbccedp/pdf/national_report.pdf. Updated 2005. Accessed Oct 14, 2013.
  7. 7.
    Moran MS, Goss D, Haffty BG, Kaufman CS, Winchester DP. Quality measures, standards, and accreditation for breast centers in the United States. Int J Radiat Oncol Biol Phys. 2010;76:1–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009;99:488–90.PubMedCrossRefGoogle Scholar
  9. 9.
    Kaufman CS, Shockney L, Rabinowitz B, et al. National quality measures for breast centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377–85.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516–23.PubMedCrossRefGoogle Scholar
  11. 11.
    Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.PubMedCrossRefGoogle Scholar
  12. 12.
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.PubMedCrossRefGoogle Scholar
  13. 13.
    Eastman A, Tammaro Y, Moldrem A, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013;20:1880–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Wagner JL, Warneke CL, Mittendorf EA, et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254:119–24.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Bleicher RJ, Ruth K, Sigurdson ER, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30:4485–92.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Pocock B, Nash S, Klein L, El-Tamer M, Schnabel FR, Joseph KA. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ. Am J Surg. 2007;194:521–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Fedewa SA, Ward EM, Stewart AK, Edge SB. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study, 2004–2006. J Clin Oncol. 2010;28:4135–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM. Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved. 2011;22:128–41.PubMedGoogle Scholar
  19. 19.
    Desantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63:151–66.PubMedCrossRefGoogle Scholar
  20. 20.
    Sturtz LA, Melley J, Mamula K, Shriver CD, Ellsworth RE. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC Cancer. 2014;14:62.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Makoul G, Arntson P, Schofield T. Health promotion in primary care: physician–patient communication and decision making about prescription medications. Soc Sci Med. 1995;41:1241–54.PubMedCrossRefGoogle Scholar
  22. 22.
    Safran DG, Kosinski M, Tarlov AR, et al. The primary care assessment survey: tests of data quality and measurement performance. Med Care. 1998;36:728–39.PubMedCrossRefGoogle Scholar
  23. 23.
    Fleming DA, Sheppard VB, Mangan PA, et al. Caregiving at the end-of-life: perceptions of healthcare quality and quality of life among patients and caregivers. J Pain Symptom Manage. 2005;31:407–20.CrossRefGoogle Scholar
  24. 24.
    Sheppard VB, Wang J, Yi B, et al. Are health-care relationships important for mammography adherence in Latinas? J Gen Intern Med. 2008;23:2024–30.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Bird ST, Bogart LM. Perceived race-based and socioeconomic status (SES)-based discrimination in interactions with health care providers. Ethn Dis. 2001;11:554–63.PubMedGoogle Scholar
  26. 26.
    Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38:209–18.PubMedCrossRefGoogle Scholar
  27. 27.
    Shelton RC, Clarke Hillyer G, Hershman DL, et al. Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Res Treat. 2013;137:817–28.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32:35–42.PubMedCrossRefGoogle Scholar
  29. 29.
    Sheppard VB, Wallington SF, Willey SC, et al. A peer-led decision support intervention improves decision outcomes in black women with breast cancer. J Cancer Educ. 2013;28:262–9.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Rizzo M, Lund MJ, Mosunjac M, et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer. 2009;115:3009–15.PubMedCrossRefGoogle Scholar
  31. 31.
    Mamounas EP, Tang G, Fisher B, et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor–positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol. 2010;28:1677–83.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Eknoyan G. Adolphe Quetelet (1796–1874)—the average man and indices of obesity. Nephrol Dial Transplant. 2008;23:47–51.PubMedCrossRefGoogle Scholar
  33. 33.
    Bustami RT, Shulkin DB, O’Donnell N, Whitman ED. Variations in time to receiving first surgical treatment for breast cancer as a function of racial/ethnic background: a cohort study. JRSM Open. 2014;5:2042533313515863.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    McGee SA, Durham DD, Tse CK, Millikan RC. Determinants of breast cancer treatment delay differ for African American and white women. Cancer Epidemiol Biomarkers Prev. 2013;22:1227–38.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the united states: trends and predictors of delays. Ann Surg. 2011;253:779–85.PubMedCrossRefGoogle Scholar
  36. 36.
    Simunovic M, Theriault ME, Paszat L, et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993–2000. Can J Surg. 2005;48:137–42.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Sheppard VB, Faul LA, Luta G, et al. Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901. J Clin Oncol. 2014;32:2318–27.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Fayanju OM, Jeffe DB, Elmore L, Ksiazek DN, Margenthaler JA. Breast cancer patients’ experiences within and outside the safety net. J Surg Res. 2014;190:126–33.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Fayanju OM, Jeffe DB, Elmore L, Ksiazek DN, Margenthaler JA. Patient and process factors associated with late-stage breast cancer diagnosis in safety-net patients: a pilot prospective study. Ann Surg Oncol. 2013;20:723–32.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Smith SK, Nicolla J, Zafar SY. Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract. 2014;10:e368–72.PubMedCrossRefGoogle Scholar
  41. 41.
    McMullan M. Patients using the Internet to obtain health information: how this affects the patient–health professional relationship. Patient Educ Couns. 2006;63:24–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Bender JL, Katz J, Ferris LE, Jadad AR. What is the role of online support from the perspective of facilitators of face-to-face support groups? A multi-method study of the use of breast cancer online communities. Patient Educ Couns. 2013;93:472–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Bender JL, Jimenez-Marroquin MC, Ferris LE, Katz J, Jadad AR. Online communities for breast cancer survivors: a review and analysis of their characteristics and levels of use. Support Care Cancer. 2013;21:1253–63.PubMedCrossRefGoogle Scholar
  44. 44.
    Maly RC, Stein JA, Umezawa Y, Leake B, Anglin MD. Racial/ethnic differences in breast cancer outcomes among older patients: effects of physician communication and patient empowerment. Health Psychology. 2008;27:728–36.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Bensink ME, Ramsey SD, Battaglia T, et al. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the patient navigation research program. Cancer. 2014;120:570–8.PubMedCentralPubMedCrossRefGoogle Scholar
  46. 46.
    Freund KM, Battaglia TA, Calhoun E, et al. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst. 2014;106:dju115.Google Scholar
  47. 47.
    Paskett ED, Katz ML, Post DM, et al. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev. 2012;21:1620–8.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Madore S, Kilbourn K, Valverde P, Borrayo E, Raich P. Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients. Support Care Cancer. 2014;22:2085–93.PubMedCrossRefGoogle Scholar
  49. 49.
    Sheppard VB, Williams KP, Harrison TM, et al. Development of decision-support intervention for black women with breast cancer. Psychooncology. 2010;19:62–70.PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Davis C, Darby K, Likes W, Bell J. Social workers as patient navigators for breast cancer survivors: what do African-American medically underserved women think of this idea? Soc Work Health Care. 2009;48:561–78.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2015

Authors and Affiliations

  • Vanessa B. Sheppard
    • 1
  • Bridget A. Oppong
    • 2
  • Regina Hampton
    • 3
  • Felicia Snead
    • 4
  • Sara Horton
    • 5
  • Fikru Hirpa
    • 9
  • Echo J. Brathwaite
    • 9
  • Kepher Makambi
    • 6
  • S. Onyewu
    • 7
  • Marc Boisvert
    • 8
  • Shawna Willey
    • 2
  1. 1.Breast Cancer Program and Office of Minority Health and Health DisparitiesLombardi Comprehensive Cancer Center, Georgetown University Medical CenterWashingtonUSA
  2. 2.Department of SurgeryMedstar Georgetown University HospitalWashingtonUSA
  3. 3.Signature Breast CareGreenbeltUSA
  4. 4.UPMC Cancer CenterPittsburghUSA
  5. 5.Department of OncologyHoward University HospitalWashingtonUSA
  6. 6.Department of BiostatisticsGeorgetown University Medical CenterWashingtonUSA
  7. 7.Department Of Surgery, Outcomes Research CenterHoward University HospitalWashingtonUSA
  8. 8.Medstar Washington Hospital CenterWashingtonUSA
  9. 9.Department of OncologyGeorgetown University Medical CenterWashingtonUSA

Personalised recommendations